New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026by krapalmJune 1, 2026PR Newswire
Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Buildersby krapalmJune 1, 2026PR Newswire
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment’s Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczemaby krapalmJune 1, 2026PR Newswire
Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meetingby krapalmJune 1, 2026PR Newswire
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Conceptby krapalmJune 1, 2026PR Newswire
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026by krapalmMay 31, 2026PR Newswire
Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data providerby krapalmMay 31, 2026PR Newswire
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Sessionby krapalmMay 31, 2026PR Newswire
AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Techby krapalmMay 31, 2026PR Newswire
Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contendersby krapalmMay 31, 2026PR Newswire
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancetby krapalmMay 31, 2026PR Newswire
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026by krapalmMay 31, 2026PR Newswire
THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®by krapalmMay 31, 2026PR Newswire
THE KILLERS ระเบิดความมันส์ในโชว์เปิดสนามนัดชิงชนะเลิศการแข่งขันยูฟ่าแชมเปียนส์ลีกที่นำเสนอโดย PEPSI®by krapalmMay 31, 2026PR Newswire
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCOby krapalmMay 30, 2026PR Newswire
